Lesson plan

LSR-3000

LSR-3000 is a non-selective serotonin receptor agonist and psychoplastogen of the tryptamine family which is under development for the treatment of neurological disorders. The drug is taken by mouth. It is under development by Lusaris Therapeutics. As of November 2022, LSR-3000 is in the research or discovery stage of development. Its chemical structure does not yet appear to have been disclosed.

Back to article

Article summary

LSR-3000 is a non-selective serotonin receptor agonist and psychoplastogen of the tryptamine family which is under development for the treatment of neurological disorders. The drug is taken by mouth. It is under development by Lusaris Therapeutics. As of November 2022, LSR-3000 is in the research or discovery stage of development. Its chemical structure does not yet appear to have been disclosed.

Key claims

No claims recorded.

Discussion questions

  1. Summarise the article in your own words. Which single claim would you verify first, and why?
  2. Which claim in this article is most likely to be revised as the sources update? How would you check its current status?
  3. If two sources disagreed about one of these facts, what would you need in order to trust one over the other?

Bibliography

No sources recorded.

Key claims and bibliography are generated from the same tracked claims and sources as the article page.